Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Nao Tokai"'
Autor:
Nao Tokai, Shuzo Yoshida, Takuya Kotani, Ayaka Yoshikawa, Yuko Kimura, Youhei Fujiki, Yoko Matsumura, Tohru Takeuchi, Shigeki Makino, Shigeki Arawaka
Publikováno v:
PLoS ONE, Vol 14, Iss 1, p e0211750 (2019)
[This corrects the article DOI: 10.1371/journal.pone.0202601.].
Externí odkaz:
https://doaj.org/article/525ec669571f47e8b29e934e5b99896f
Autor:
Nao Tokai, Shuzo Yoshida, Takuya Kotani, Ayaka Yoshikawa, Yuko Kimura, Youhei Fujiki, Yoko Matsumura, Tohru Takeuchi, Shigeki Makino, Shigeki Arawaka
Publikováno v:
PLoS ONE, Vol 13, Iss 8, p e0202601 (2018)
OBJECTIVE:The aim of this study was to clarify whether serum matrix metalloproteinase 3 (MMP-3) levels are associated with an effect of iguratimod as add-on therapy to biological DMARDs (bDMARDs) in patients with rheumatoid arthritis (RA). METHODS:Fo
Externí odkaz:
https://doaj.org/article/1c035ce91a4046919099ae42f562bbbb
Autor:
Daisuke Fujita, Tohru Takeuchi, Yumiko Wada, Takuya Kotani, Eri Nakamura, Ayaka Yoshikawa, Yuri Hiramatsu, Yoko Matsumura, Kenichiro Hata, Nao Tokai
Objectives We explored rheumatoid arthritis (RA) disease activity before, during, and after pregnancy in patients treated with tight control and investigated the association between disease activity in the postpartum period and those before and durin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::72f3080f2f4102c928cf476f7baf1f4f
Autor:
Takuya Kotani, Takuro Ozaki, Ayaka Yoshikawa, Toru Takeuchi, Shigeki Arawaka, Nao Tokai, Yuko Kimura, Yoko Matsumura, Shigeki Makino, Shuzo Yoshida, Koji Nagai
Publikováno v:
International Journal of Rheumatic Diseases. 22:81-89
Aim To investigate whether remission can be sustained for rheumatoid arthritis (RA) patients after tapering abatacept (ABT). Method All patients were naive to biological disease-modifying anti-rheumatic drugs (bDMARDs) and in low or moderate Disease
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5e1de2e52f8953356a379099ae62149e
https://doi.org/10.1111/1756-185x.13384
https://doi.org/10.1111/1756-185x.13384
Autor:
Eri Nakamura, Takuya Kotani, Yuri Hiramatsu, Kenichiro Hata, Ayaka Yoshikawa, Yoko Matsumura, Nao Tokai, Yumiko Wada, Daisuke Fujita, Tohru Takeuchi
Publikováno v:
Modern Rheumatology; July 2021, Vol. 31 Issue 4, p809-816, 8p
Autor:
Ayaka Yoshikawa, Yuko Kimura, Nao Tokai, Yoko Matsumura, Shigeki Makino, Shuzo Yoshida, Yohei Fujiki, Takuya Kotani, Tohru Takeuchi
Publikováno v:
Modern rheumatology. 28(2)
In this study, iguratimod (IGU) was added to rheumatoid arthritis (RA) patients inadequately responding to 24-week or longer treatment with biological disease-modifying antirheumatic drug (bDMARDs), its effectiveness was assessed, and factors contrib
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::affc1bd1df87f35b9567161c9057f6ed
https://pubmed.ncbi.nlm.nih.gov/28644744
https://pubmed.ncbi.nlm.nih.gov/28644744
Autor:
Yoko Matsumura, Takuya Kotani, Ayaka Yoshikawa, Youhei Fujiki, Nao Tokai, Tohru Takeuchi, Shigeki Arawaka, Shigeki Makino, Yuko Kimura, Shuzo Yoshida
Publikováno v:
PLoS ONE, Vol 14, Iss 1, p e0211750 (2019)
Objective The aim of this study was to clarify whether serum matrix metalloproteinase 3 (MMP-3) levels are associated with an effect of iguratimod as add-on therapy to biological DMARDs (bDMARDs) in patients with rheumatoid arthritis (RA). Methods Fo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e8b223725f0339e56cc454ad00f90d8c
https://doi.org/10.1371/journal.pone.0211750
https://doi.org/10.1371/journal.pone.0211750
Autor:
Takayuki Kon, Naoto Tamura, Ken Yamaji, Nao Tokai, Kurisu Tada, Yoshinari Takasaki, Takuya Nemoto, Go Murayama, Michihiro Ogasawara, Seiichiro Ando, Kentaro Minowa, Misa Gorai, Nagachika Sugisaki, Masakazu Matsushita, Yusuke Yamada, Shigeki Makino, Yuko Matsuki
Publikováno v:
Modern rheumatology. 25(4)
Treatment for rheumatoid arthritis (RA) should aim to achieve full remission. The aim of this study was to investigate predictors of persistent subclinical synovitis and whether longer clinical remission is effective in reducing subclinical synovitis
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6e24105faae6376735bd101b3d877321
https://pubmed.ncbi.nlm.nih.gov/25496404
https://pubmed.ncbi.nlm.nih.gov/25496404
Autor:
Ayaka Yoshikawa, Shuzo Yoshida, Yuko Kimura, Nao Tokai, Yohei Fujiki, Takuya Kotani, Yoko Matsumura, Tohru Takeuchi, Shigeki Makino
Publikováno v:
Modern Rheumatology; 2018, Vol. 28 Issue 2, p227-234, 8p